- NIH Fiscal Policy for Grant Awards - FY2015 (NOT-OD-15-050)
- Ruth L. Kirschstein National Research Service Award (NRSA) Stipends, Tuition/Fees and Other Budgetary Levels Effective for Fiscal Year 2015 (NOT-OD-15-048)
- Notice on Salary Limitation on Grants, Cooperative Agreements, and Contracts (NOT-OD-15-049)
FY 2015 Funding Levels: Non-competing continuation awards that have already been made in FY 2015 were generally funded at levels below that indicated on the most recent Notice of Award (generally up to 90% of the previously committed level) as described in NOT-OD-15-001. Such reductions may be fully or partially restored, depending on the Institute or Center. Non-competing continuation grants (research and non-research) including those that remain to be issued in FY 2015 likely will be made within the range between the commitment level indicated on the Notice of Award and 3 percent below that level. Out-year commitments for continuation awards in FY 2016 and beyond will remain unchanged. The NIH awarding Institutes/Centers (IC) will develop and post their fiscal policies consistent with overall NIH goals and available FY 2015 funds.
Ruth L. Kirschstein National Research Service Awards (NRSA): Consistent with the 2015 Consolidated and Further Continuing Appropriations Act and with the recommendations of the Advisory Committee to the Director regarding the Biomedical Research Workforce, the NIH will increase NRSA stipends by 2 percent on average. The full range of stipend adjustments for FY 2015 is described at NOT-OD-15-048.
New Investigators: NIH will continue to support new investigators on R01 equivalent awards at success rates comparable to that of established investigators submitting new (Type 1) R01 equivalent applications. Achievement of comparable success rates should permit the NIH to support new investigators in accordance with the policies established in FY 2009 and subsequent years as described at NOT-OD-09-013 and at http://grants.nih.gov/grants/new_investigators/index.htm.
Salary Limits: Section 203 of the 2015 Consolidated and Further Continuing Appropriations Act prohibits payments for salaries under grants and other extramural mechanisms in excess of Executive Level II currently set at $181,500. See NOT-OD-15-049 for additional information. NOT-OD-15-049 states that the “Executive Level II salary is currently set at $181,500, increasing to $183,300 effective January 11, 2015.”
Other Legislative Mandates: Other statutory requirements will be described in a notice to be released early in January.
Additional Information: Additional details on Fiscal Operations, including specific funding strategies for ICs will be posted at http://grants.nih.gov/grants/financial/index.htm.
January 12 Update: NIH has posted Notice of Legislative Mandates in Effect for FY 2015 (NOT-OD-15-054), with additional information on statutory provisions that limit the use of funds on NIH grant, cooperative agreement, and contract awards for FY 2015.
